8-K: Vaxart Receives Stop Work Order from ATI for BARDA-Funded Project

Vaxart, Inc. has been issued a stop work order by Advanced Technology International (ATI) for its BARDA-funded project, impacting all efforts except for the per protocol follow-up for the 400-person cohort.

Summary

• Vaxart, Inc. received a written notification from Advanced Technology International (ATI) on February 21, 2025, directing the company to stop work on its project agreement.
• The project agreement, No. 01; RRPV-24-04-NGVx-003, was dated June 13, 2024, and involved ATI, the Rapid Response Partnership Vehicles Consortium Management Firm funded by BARDA.
• The stop work order impacts all of Vaxart's efforts related to the agreement, except for the per protocol follow-up for the 400-person cohort.
• The notice states that the stop work order is in effect for 90 days.
• Within this 90-day period, ATI, as directed by the Government, will either cancel the stop-work order, extend it, or terminate the work covered by the Project Agreement.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the stop work order, which introduces uncertainty and potential financial risks for Vaxart.

Negatives

• Vaxart has received a stop work order, which halts most of its work on a BARDA-funded project.
• The future of the project is uncertain, as ATI may choose to extend the stop work order or terminate the agreement.

Risks

• The stop work order could be extended or the project could be terminated, impacting Vaxart's financials and future prospects.
• The company's ability to achieve milestones and deliverables under the Project Agreement is now at risk.
• The company's continuing operating losses could be exacerbated by the loss of funding from the project.
• There is a risk that the company will not receive any additional funding under the Project Agreement.

Future Outlook

The company's future depends on whether ATI, BARDA, or another part of the United States government may take to cancel the stop work order, extend the stop work order, or terminate the work covered by the Project Agreement.

Industry Context

This announcement highlights the risks associated with government-funded research and development projects, where funding can be uncertain and subject to changing priorities.

Stakeholder Impact

• Shareholders face increased uncertainty due to the potential loss of funding and project termination.
• Employees working on the project may face job insecurity.
• The development of the related vaccine or therapeutic may be delayed or terminated.

Next Steps

• ATI will decide within 90 days whether to cancel, extend, or terminate the stop work order.

Key Dates

Keywords

Vaxart, ATI, BARDA, Stop Work Order, Project Agreement, Funding, Termination